This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005;25(5):341-5.

doi: 10.2165/00044011-200525050-00007.

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

Christof Schöfl¹, Georg Luebben

Affiliations

PMID: 17532672
DOI: 10.2165/00044011-200525050-00007

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

Christof Schöfl et al. Clin Drug Investig. 2005.

. 2005;25(5):341-5.

doi: 10.2165/00044011-200525050-00007.

Authors

Christof Schöfl¹, Georg Luebben

Affiliation

¹ Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany.

PMID: 17532672
DOI: 10.2165/00044011-200525050-00007

No abstract available

PubMed Disclaimer

Similar articles

Therapies for diabetic dyslipidaemia.
Bell DS, Al Badarin F, O'Keefe JH Jr. Bell DS, et al. Diabetes Obes Metab. 2011 Apr;13(4):313-25. doi: 10.1111/j.1463-1326.2010.01342.x. Diabetes Obes Metab. 2011. PMID: 21205114 Review.
Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.
Keating GM, Croom KF. Keating GM, et al. Drugs. 2007;67(1):121-53. doi: 10.2165/00003495-200767010-00013. Drugs. 2007. PMID: 17209672 Review.
Diabetic dyslipidaemia: insights for optimizing patient management.
Vergès B. Vergès B. Curr Med Res Opin. 2005;21 Suppl 1:S29-40. doi: 10.1185/030079905X36468. Curr Med Res Opin. 2005. PMID: 15811197 Review.
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.
Al Majali K, Cooper MB, Staels B, Luc G, Taskinen MR, Betteridge DJ. Al Majali K, et al. Diabetologia. 2006 Mar;49(3):527-37. doi: 10.1007/s00125-005-0092-4. Epub 2006 Jan 21. Diabetologia. 2006. PMID: 16429317 Clinical Trial.
Pioglitazone plus glimepiride: a promising alternative in metabolic control.
Derosa G. Derosa G. Int J Clin Pract Suppl. 2007 Jun;(153):28-36. doi: 10.1111/j.1742-1241.2007.01362.x. Int J Clin Pract Suppl. 2007. PMID: 17594391 Review.

See all similar articles

Cited by

Pioglitazone for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Richter B, et al. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006060. doi: 10.1002/14651858.CD006060.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054272 Free PMC article.

References

1. Coron Artery Dis. 2001 Aug;12(5):413-23 - PubMed
1. Diabetes Care. 2004 Jan;27(1):141-7 - PubMed
1. Diabetes. 1997 Jan;46(1):63-9 - PubMed
1. Diabetes Care. 2003 Sep;26(9):2588-94 - PubMed
1. Clin Ther. 2000 Dec;22(12):1395-409 - PubMed

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer